Eden
A polished, high-disclosure compounded program with strong nationwide coverage.
Visit EdenHead-to-head verdict
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
A polished, high-disclosure compounded program with strong nationwide coverage.
Visit EdenA weight-focused program that also offers an oral/sublingual route for the needle-averse.
Visit ShedRxEden takes it with a higher Verdict Score — 91/100 to 87/100 (grade A− vs B+). People who prioritize a vetted, high-transparency provider over the lowest sticker price. ShedRx still earns its place — people who want an oral or sublingual option rather than weekly injections.
Neither of these is our overall #1. That title goes to CoreAge Rx (94/100) — the most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
| Metric | Eden | ShedRx |
|---|---|---|
| Verdict Score | 91/100 | 87/100 |
| Grade | A− | B+ |
| Semaglutide | $239/mo | $199/mo |
| Tirzepatide | $349/mo | $299/mo |
| Coverage | All 50 states | Not disclosed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | Yes |
What we like
The caveats
What we like
The caveats
Our pick — visit
People who prioritize a vetted, high-transparency provider over the lowest sticker price.
Visit Eden Read the full Eden review →Also worth a look
People who want an oral or sublingual option rather than weekly injections.
Visit ShedRx Read the full ShedRx review →Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.